Overview
Celebrating its 30th year, the Acute Leukemia Forum (ALF) continues its tradition of being a premier event for hematology and oncology professionals. This milestone conference brings together leading experts to share groundbreaking research and clinical advances that shape the treatment and management of acute leukemia and myelodysplastic syndromes. As we look ahead to 2026, ALF will focus on addressing the evolving educational needs of those involved in the care of patients with these challenging malignancies.
Join us as we commemorate three decades of progress and collaboration! We look forward to you joining our community of healing at the 30th Acute Leukemia Forum, April 2026, in San Diego, California.
Meet the Chairs
Daniel A. Pollyea, MD, MS
Professor of Medicine Clinical Director of Leukemia Services Associate Chief of Clinical Affairs Robert H. Allen MD Chair in Hematology Research Division of Hematology University of Colorado School of Medicine Aurora, Colorado
Eytan M. Stein, MD
Chief, Leukemia Service Director Program for Drug Development in Leukemia Associate Attending Physician Department of Medicine Memorial Sloan Kettering Cancer Center New York, New York
Hetty E. Carraway, MD, MBA
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Director, Leukemia Program
Vice Chair Strategy and Enterprise Development
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio
Sign Up for Updates!
Stay up to date on the latest for 30th Acute Leukemia Forum 2026 by entering your email address below.
Disclaimer: Entering your email address automatically subscribes you to future email communications from MedscapeLIVE events. This does not qualify as a registration for the conference.